SKI Market

A+| A| A-|

Indian Indices

Sensex

75,315.04 77.05
( 0.10%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

60,874.73 -534.56
(-0.87%)

Nikkei 225

10,172.40 -200.53
(-1.93%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Venus Remedies Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

526953

INE411B01019

467.2458657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VENUSREM

17.28

1220.47

EPS(TTM)

Face Value()

Div & Yield %

52.85

Back

simplex papers ltd

Lenskart Solutions announces incorporation of stepdown subsidiary - Stellio Ventures UK

Jan 06,2026

Stellio Ventures, S.L. (Stellio), a subsidiary of the Lenskart Solutions, has incorporated a wholly owned subsidiary namely Stellio Ventures UK (Stellio UK) in England and Wales, UK and accordingly, it has become a step-down subsidiary of the Company effective 05 January 2026.

Stellio UK is incorporated with the objective for sale of eyewear products and related accessories under the ‘Meller' brand in the United Kingdom.

75,315.04 77.05 ( 0.10%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

60,874.73 -534.56 (-0.87%)

10,172.40 -200.53 (-1.93%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)